Production of a probiotic composition
US-2024293479-A1 · Sep 5, 2024 · US
US2016367979A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016367979-A1 |
| Application number | US-201515120820-A |
| Country | US |
| Kind code | A1 |
| Filing date | Feb 27, 2015 |
| Priority date | Mar 24, 2014 |
| Publication date | Dec 22, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The purpose of the present invention is to provide a method for separating and concentrating a target substance as an alternative to existing cationic polymers, and a kit for implementing this method.
Opening claim text (preview).
1 . A method for separating and concentrating a target substance using a cationic graft polymer, comprising: (1) step of bringing the cationic graft polymer into contact with a sample containing the target substance to make the target substance bound to the cationic graft polymer under a basic condition; (2) step of separating the bound complex of the cationic graft polymer and the target biomolecule; and (3) step of eluting the target substance from the bound complex, wherein the cationic graft polymer is a polyamine graft polymer obtained by polymerizing a polyamine derivative obtained by a reaction between (a) a polymer compound having at least one amino group and (b) a compound having at least one epoxy group, and (c) an ethylenically unsaturated monomer. 2 . The method according to claim 1 , further comprising adding a divalent or trivalent metal ion in step (1). 3 . The method according to claim 1 , further comprising a step for washing the bound complex in step (2). 4 . The method according to claim 1 , wherein the cationic graft polymer is fixed to a solid phase surface. 5 . The method according to claim 1 , comprising a step for aggregating a cationic graft polymer which is not bound to the target substance in step (3). 6 . A kit used for the method according to claim 1 , comprising a cationic graft polymer. 7 . The kit according to claim 6 , further comprising a divalent or trivalent metal ion salt. 8 . The kit according to claim 6 , further comprising a reaction solution containing a basic solution and a divalent or trivalent metal ion salt. 9 . The kit according to claim 6 , further comprising a washing solution. 10 . The kit according to claim 6 , further comprising a dispersion solution containing an acidic solution or a chelating agent. 11 . The kit according to claim 6 , further comprising an aggregation solution.
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00) · CPC title
Affinity chromatography · CPC title
Purification (C12M47/04 takes precedence) · CPC title
Separating microorganisms from their culture media · CPC title
obtained by reactions only involving carbon to carbon unsaturated bonds (macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds per se C08F) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.